Smith, E.
Ottosson, F.
Ericson, U.
Hellstrand, S.
Rizzo, M.
Sukruang, K.
Pizza, V.
Orho-Melander, M.
Nilsson, P. M.
Kennbäck, C.
Fernandez, C.
Antonini, P.
Di Somma, S.
Melander, O.
Funding for this research was provided by:
Ernhold Lundströms stiftelse
Hulda och E Conrad Mossfelts Stiftelse för Vetenskaplig Forskning Inom Hjärt- och Kärlsjukdomarnas Område
Direktör Albert Påhlssons Stiftelse
Stiftelsen för Strategisk Forskning (IRC LUDC)
Vetenskapsrådet (SFO-EXODIAB)
Lunds Universitet (Artificially Intelligent use of Registers at Lund University)
European Research Council (AdG 2019-885003)
Novo Nordisk Fonden (NNF200C0063465)
Hjärt-Lungfonden (Dnr 20180278)
Lund University
Article History
Received: 2 January 2024
Accepted: 16 July 2024
First Online: 27 July 2024
Declarations
:
: The authors declare no competing interests.
: All participants provided oral and written informed consent. There was no financial compensation for participants. The study was approved by the Swedish Ethical Review Authority (Dnr 2019–06108).